Related Experiment Videos
Role of the different percutaneous revascularization techniques in single and multivessel coronary artery disease
T Corcos1, M Zimarino, C Tamburino
1Cardiologie Interventionnelle, Centre Médico-Chirurgical Parly-Grand Chesnay, Le Chesnay, France.
Insights
Coronary angioplasty has advanced significantly, improving success rates for coronary artery disease. However, restenosis remains a challenge, prompting comparisons with coronary bypass surgery for complex cases.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Coronary angioplasty has evolved over 16 years, becoming a standard treatment for coronary artery disease.
- Technological advancements and increased operator experience have enhanced success rates and expanded indications for percutaneous revascularization, including complex lesions.
Purpose of the Study:
- To review the mechanisms, limitations, and advancements in coronary angioplasty.
- To discuss the role of new interventional devices and a multidevice approach for complex coronary lesions.
- To highlight restenosis as a key limitation and compare angioplasty with coronary bypass surgery.
Main Methods:
- Review of established and emerging interventional cardiology techniques.
- Discussion of mechanisms of action for coronary angioplasty.
- Analysis of limitations including lesion morphology, high-risk patients, and restenosis.
- Introduction of new devices like stents, atherectomy, and laser angioplasty.
Main Results:
- Coronary angioplasty mechanisms involve plaque fracture, dissection, and stretching.
- Limitations include unfavorable lesion morphology, high-risk patients, and acute occlusion.
- New devices and a multidevice approach improve results for complex lesions.
- Restenosis remains a significant challenge, impacting long-term outcomes.
Conclusions:
- A multidevice, lesion-specific approach can optimize results for complex coronary lesions.
- Restenosis is the primary limitation of coronary angioplasty, diminishing its advantages over bypass surgery.
- Randomized trials are comparing angioplasty and coronary bypass surgery for multivessel disease.
Abstract:
Over the past 16 years coronary angioplasty has become an established therapy for coronary artery disease. Advances in technology and growing operator experience have improved initial success rates, lowered the complications associated with coronary angioplasty and expanded the indications of percutaneous revascularization to include large numbers of patients with complex lesions. The mechanisms of coronary angioplasty include plaque fracture, intimal atherosclerotic flaps, localized medial dissection and stretching of plaque-free segments. The problems and limitations of coronary angioplasty are: unfavourable lesion morphology which may preclude complete revascularization or increase the risk of major complications, "high-risk" patients requiring pharmacological or mechanical support, acute coronary occlusion, and restenosis, the 2 latter problems being related to the very mechanisms of coronary angioplasty. Recently, new interventional devices have been introduced: intracoronary stents, directional coronary atherectomy, rotational atherectomy, transluminal extraction atherectomy, excimer laser coronary angioplasty. A multidevice lesion-specific approach integrated with balloon angioplasty may optimize procedural results in a growing number of patients with complex coronary lesions. However, restenosis occurring within 6 months after successful angioplasty remains the "Achilles' heel" of coronary interventional procedures and erodes the potential advantages angioplasty holds over coronary bypass surgery. These 2 forms of myocardial revascularization are currently compared for the treatment of multivessel disease in randomized trials.